d-Propoxyphene kinetics after single oral and intravenous doses in man
- PMID: 487695
- DOI: 10.1002/cpt1979264473
d-Propoxyphene kinetics after single oral and intravenous doses in man
Abstract
d-Propoxyphene kinetics was studied in 8 healthy male subjects after single oral doses of d-propoxyphene at 65, 130, and 190 mg and after slow intravenous infusion of 65 mg. Total urinary excretion (7 days) indicated complete oral absorption but systemic availability was reduced corresponding to fist-pass elimination of 30% to 70%. There was linearity between oral dose and the corresponding area under the plasma concentration/time curve of d-propoxyphene and the metabolite norpropoxyphene. The kinetic measurements showed 2- to 3-fold interindividual variations: oral clearance, 1.3 to 3.6 1/min; systemic clearance, 0.6 to 1.2 1/min; apparent volume of distribution, 700 to 1,800 1; d-propoxyphene half-life (t1/2), 8 to 24 hr; and norpropoxyphene t1/2, 18 to 29 hr. There were pronounced intraindividual dose-dependent variations in oral clearance in some subjects. The intravenous concentration curves indicated a 3-compartment distribution model.
Similar articles
-
D-propoxyphene and norpropoxyphene kinetics after the oral administration of D-propoxyphene: a new approach to liver function?J Hepatol. 1994 Sep;21(3):283-91. doi: 10.1016/s0168-8278(05)80303-4. J Hepatol. 1994. PMID: 7836695 Clinical Trial.
-
Propoxyphene and norpropoxyphene plasma concentrations in the anephric patient.Clin Pharmacol Ther. 1980 May;27(5):665-70. doi: 10.1038/clpt.1980.94. Clin Pharmacol Ther. 1980. PMID: 7371364
-
The effect of ethanol intake on propoxyphene absorption and biotransformation in dogs.Alcohol Clin Exp Res. 1986 Aug;10(4):393-6. doi: 10.1111/j.1530-0277.1986.tb05111.x. Alcohol Clin Exp Res. 1986. PMID: 3530016
-
Propoxyphene and norpropoxyphene plasma concentrations after oral propoxyphene in cirrhotic patients with and without surgically constructed portacaval shunt.Clin Pharmacol Ther. 1980 Sep;28(3):417-24. doi: 10.1038/clpt.1980.182. Clin Pharmacol Ther. 1980. PMID: 7408401
-
High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.Clin Pharmacokinet. 1986 Mar-Apr;11(2):87-106. doi: 10.2165/00003088-198611020-00001. Clin Pharmacokinet. 1986. PMID: 3514045 Review.
Cited by
-
First-pass elimination. Basic concepts and clinical consequences.Clin Pharmacokinet. 1984 Jan-Feb;9(1):1-25. doi: 10.2165/00003088-198409010-00001. Clin Pharmacokinet. 1984. PMID: 6362950 Review.
-
Individual variation in first-pass metabolism.Clin Pharmacokinet. 1993 Oct;25(4):300-28. doi: 10.2165/00003088-199325040-00005. Clin Pharmacokinet. 1993. PMID: 8261714 Review.
-
Dextropropoxyphene kinetics after single and repeated oral doses in man.Eur J Clin Pharmacol. 1985;29(1):79-84. doi: 10.1007/BF00547373. Eur J Clin Pharmacol. 1985. PMID: 4054208
-
Pharmacokinetics of drug overdose.Clin Pharmacokinet. 1981 May-Jun;6(3):161-92. doi: 10.2165/00003088-198106030-00001. Clin Pharmacokinet. 1981. PMID: 7016383 Review.
-
[Sustained-release dextropropoxyphene.].Schmerz. 1991 Dec;5(4):233-42. doi: 10.1007/BF02527803. Schmerz. 1991. PMID: 18415177 German.